# Clobetasol for Oral Graft-Versus-Host Disease

> **NCT01557517** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 40 (actual)

## Conditions studied

- Oral Chronic Graft vs Host Disease

## Interventions

- **DRUG:** Clobetasol Oral Rinse
- **DRUG:** Placebo oral rinse

## Key facts

- **NCT ID:** NCT01557517
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03-28
- **Primary completion:** 2017-06-09
- **Final completion:** 2017-08-24
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01557517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01557517, "Clobetasol for Oral Graft-Versus-Host Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01557517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*